JUN 23, 2020 10:00 AM PDT

Mesenchymal stromal or stem cell (MSC) workflow for efficient clinical translation: from automated GMP-compliant cell manufacturing to standardized phenotyping

Sponsored by: Miltenyi Biotec
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

DATE:  June 23, 2020

TIME:  10:00am PT

 

Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, such as COVID-19 disease. Several clinical trials have been started, and preliminary data hold great promise for clinical use and cell therapy for this severe disease. To facilitate efficient clinical translation, we developed an automated GMP-compliant cell manufacturing procedure using the integrated cell processing platform CliniMACS Prodigy®, which increases the level of process standardization and product safety. In this new adherent cell culture (ACC) system, sample cells are processed in a closed system, including automated density gradient centrifugation in case of human bone marrow sample, feeding, replating, expanding, and harvesting procedures. Clinical applications of MSCs for spine and joint pain needs only small amount stem cells injected locally. However, for systemic illness such as COVID-19, millions of cells are needed for IV inject. Our xeno-free MSC-Brew GMP Medium, following the recommendations of USP <1043> on ancillary materials, enables efficient isolation and expansion of MSCs from different tissue sources including human bone marrow, adipose tissue, and umbilical cord. Together with the ACC system,  over 200 million MSCs can be generated from single donor in just 14 days. Cultured MSCs need to go through strict quality control before any clinical applications. Our new MSC phenotyping kit, including 3 positive and 5 negative MSC markers based on ISCT standard, facilitates standardized and reliable phenotyping of cultured human MSCs from different tissue sources. The high-purity recombinant engineered antibodies (REAfinity™) in the kit ensures high lot-to-lot consistency and reproducible results in flow cytometry.  

 

Learning objectives:

  • Discuss GMP grade serum-free and xeno-free Medium for efficient MSCs expansion from different tissue resources
  • Discuss Automated and closed Adherent Cell Culture (ACC) System for GMP scale MSC production
  • Discuss Standardized and reliable phenotyping of cultured MSCs

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
Loading Comments...
Show Resources